Advertisement
Correspondence| Volume 70, ISSUE 5, e31-e32, September 01, 2011

Brain-Derived Neurotrophic Factor Predicts Physical Health in Untreated Patients with Hepatitis C

      Brain-derived neurotrophic factor (BDNF), as the most abundant growth factor in the brain, has several functions in neural development and regeneration (
      • Binder D.K.
      • Scharfman H.E.
      Brain-derived neurotrophic factor.
      ). This factor may be involved in mood disorders, cognitive problems, and chronic fatigue syndrome (
      • Binder D.K.
      • Scharfman H.E.
      Brain-derived neurotrophic factor.
      ,
      • Hashimoto K.
      • Shimizu E.
      • Iyo M.
      Critical role of brain-derived neurotrophic factor in mood disorders.
      ,
      • Chen R.
      • Liang F.X.
      • Moriya J.
      • Yamakawa J.
      • Sumino H.
      • Kanda T.
      • Takahashi T.
      Chronic fatigue syndrome and the central nervous system.
      ). Hepatitis C virus (HCV) is thought to cause neuropsychiatric symptoms, such as mood disturbances, fatigue, and impaired physical and mental aspects of quality of life independent of the disease activity, or cirrhosis (
      • Foster G.R.
      Quality of life considerations for patients with chronic hepatitis C.
      ,
      • Foster G.R.
      • Goldin R.D.
      • Thomas H.C.
      Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.
      ). In one study, patients with HCV had lower physical health scores but similar mental health scores compared with patients with hepatitis B virus (HBV) (
      • Foster G.R.
      • Goldin R.D.
      • Thomas H.C.
      Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.
      ). Many authors have argued that these symptoms might be related to using interferon, drug abuse, or disease chronicity (
      • Foster G.R.
      Quality of life considerations for patients with chronic hepatitis C.
      ,
      • Yamini D.
      • Basseri B.
      • Chee G.M.
      • Arakelyan A.
      • Enayati P.
      • Tran T.T.
      • Poordad F.
      Tobacco and other factors have a negative impact on quality of life in hepatitis C patients [published online ahead of print August 15].
      ), while others believe that these symptoms may reflect some kind of brain involvement in patients with HCV (
      • Forton D.M.
      • Allsop J.M.
      • Main J.
      • Foster G.R.
      • Thomas H.C.
      • Taylor-Robinson S.D.
      Evidence for a cerebral effect of the hepatitis C virus.
      ).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Binder D.K.
        • Scharfman H.E.
        Brain-derived neurotrophic factor.
        Growth Factors. 2004; 22: 123-131
        • Hashimoto K.
        • Shimizu E.
        • Iyo M.
        Critical role of brain-derived neurotrophic factor in mood disorders.
        Brain Res Rev. 2004; 45: 104-114
        • Chen R.
        • Liang F.X.
        • Moriya J.
        • Yamakawa J.
        • Sumino H.
        • Kanda T.
        • Takahashi T.
        Chronic fatigue syndrome and the central nervous system.
        J Int Med Res. 2008; 36: 867-874
        • Foster G.R.
        Quality of life considerations for patients with chronic hepatitis C.
        J Viral Hepat. 2009; 16: 605-611
        • Foster G.R.
        • Goldin R.D.
        • Thomas H.C.
        Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.
        Hepatology. 1998; 27: 209-212
        • Yamini D.
        • Basseri B.
        • Chee G.M.
        • Arakelyan A.
        • Enayati P.
        • Tran T.T.
        • Poordad F.
        Tobacco and other factors have a negative impact on quality of life in hepatitis C patients [published online ahead of print August 15].
        J Viral Hepat. 2010;
        • Forton D.M.
        • Allsop J.M.
        • Main J.
        • Foster G.R.
        • Thomas H.C.
        • Taylor-Robinson S.D.
        Evidence for a cerebral effect of the hepatitis C virus.
        Lancet. 2001; 358: 38-39
        • Cassiman D.
        • Denef C.
        • Desmet V.J.
        • Roskams T.
        Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.
        Hepatology. 2001; 33: 148-158
        • Levy M.T.
        • McCaughan G.W.
        • Marinos G.
        • Gorrell M.D.
        Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.
        Liver. 2002; 22: 93-101
        • Teuber G.
        • Schafer A.
        • Rimpel J.
        • Paul K.
        • Keicher C.
        • Scheurlen M.
        • et al.
        Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
        J Hepatol. 2008; 49: 923-929
        • Hilsabeck R.C.
        • Hassanein T.I.
        • Perry W.
        Biopsychosocial predictors of fatigue in chronic hepatitis C.
        J Psychosom Res. 2005; 58: 173-178
        • Cook D.B.
        • Lange G.
        • DeLuca J.
        • Natelson B.H.
        Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome.
        Int J Neurosci. 2001; 107: 1-6